# FDA recall D-0732-2026

> **JB Chemicals and Pharmaceuticals Ltd** · Class I · drug recall initiated 2026-06-24.

## Product

Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, India. Distributed by: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, NDC 16571-401-10.

## Reason for recall

Cross Contamination with Other Products: Customer complaints for appearance of  discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0732-2026
- **Recalling firm:** JB Chemicals and Pharmaceuticals Ltd
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-06-24
- **Report date:** 2026-07-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mumbai, N/A, India

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0732-2026

## Citation

> AI Analytics. FDA recall D-0732-2026. Retrieved 2026-08-31 from https://api.ai-analytics.org/recall/D-0732-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*